BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 35538074)

  • 1. Cumulative SARS-CoV-2 mutations and corresponding changes in immunity in an immunocompromised patient indicate viral evolution within the host.
    Sonnleitner ST; Prelog M; Sonnleitner S; Hinterbichler E; Halbfurter H; Kopecky DBC; Almanzar G; Koblmüller S; Sturmbauer C; Feist L; Horres R; Posch W; Walder G
    Nat Commun; 2022 May; 13(1):2560. PubMed ID: 35538074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of SARS-CoV-2 Spike Mutations during Prolonged Infection in Immunocompromised Hosts.
    Ko KKK; Yingtaweesittikul H; Tan TT; Wijaya L; Cao DY; Goh SS; Abdul Rahman NB; Chan KXL; Tay HM; Sim JHC; Chan KS; Oon LLE; Nagarajan N; Suphavilai C
    Microbiol Spectr; 2022 Jun; 10(3):e0079122. PubMed ID: 35543562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients.
    Pavia G; Quirino A; Marascio N; Veneziano C; Longhini F; Bruni A; Garofalo E; Pantanella M; Manno M; Gigliotti S; Giancotti A; Barreca GS; Branda F; Torti C; Rotundo S; Lionello R; La Gamba V; Berardelli L; Gullì SP; Trecarichi EM; Russo A; Palmieri C; De Marco C; Viglietto G; Casu M; Sanna D; Ciccozzi M; Scarpa F; Matera G
    J Med Virol; 2024 Jun; 96(6):e29708. PubMed ID: 38804179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yearlong COVID-19 Infection Reveals Within-Host Evolution of SARS-CoV-2 in a Patient With B-Cell Depletion.
    Nussenblatt V; Roder AE; Das S; de Wit E; Youn JH; Banakis S; Mushegian A; Mederos C; Wang W; Chung M; Pérez-Pérez L; Palmore T; Brudno JN; Kochenderfer JN; Ghedin E
    J Infect Dis; 2022 Apr; 225(7):1118-1123. PubMed ID: 34940844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants.
    Weigang S; Fuchs J; Zimmer G; Schnepf D; Kern L; Beer J; Luxenburger H; Ankerhold J; Falcone V; Kemming J; Hofmann M; Thimme R; Neumann-Haefelin C; Ulferts S; Grosse R; Hornuss D; Tanriver Y; Rieg S; Wagner D; Huzly D; Schwemmle M; Panning M; Kochs G
    Nat Commun; 2021 Nov; 12(1):6405. PubMed ID: 34737266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 shedding dynamics and transmission in immunosuppressed patients.
    Lee JS; Yun KW; Jeong H; Kim B; Kim MJ; Park JH; Shin HS; Oh HS; Sung H; Song MG; Cho SI; Kim SY; Kang CK; Choe PG; Park WB; Kim NJ; Oh MD; Choi EH; Park S; Kim TS; Lee JH; Sung H; Park SS; Seong MW
    Virulence; 2022 Dec; 13(1):1242-1251. PubMed ID: 35891618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-Host Evolution Analyses in an Immunosuppressed Patient Supports SARS-CoV-2 Viral Reservoir Hypothesis.
    Fournelle D; Mostefai F; Brunet-Ratnasingham E; Poujol R; Grenier JC; Gálvez JH; Pagliuzza A; Levade I; Moreira S; Benlarbi M; Beaudoin-Bussières G; Gendron-Lepage G; Bourassa C; Tauzin A; Grandjean Lapierre S; Chomont N; Finzi A; Kaufmann DE; Craig M; Hussin JG
    Viruses; 2024 Feb; 16(3):. PubMed ID: 38543708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo emergence of SARS-CoV-2 spike mutations in immunosuppressed patients.
    Simons LM; Ozer EA; Gambut S; Dean TJ; Zhang L; Bhimalli P; Schneider JR; Mamede JI; Ison MG; Karmali R; Gordon LI; Lorenzo-Redondo R; Hultquist JF
    Transpl Infect Dis; 2022 Dec; 24(6):e13914. PubMed ID: 35899968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 intrahost evolution in immunocompromised patients in comparison with immunocompetent populations after treatment.
    Ahmadi AS; Zadheidar S; Sadeghi K; Nejati A; Salimi V; Hajiabdolbaghi M; Mokhtari-Azad T; Yavarian J
    J Med Virol; 2023 Jun; 95(6):e28877. PubMed ID: 37341553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Cas12a-Based Detection for the Major SARS-CoV-2 Variants of Concern.
    Liang Y; Lin H; Zou L; Zhao J; Li B; Wang H; Lu J; Sun J; Yang X; Deng X; Tang S
    Microbiol Spectr; 2021 Dec; 9(3):e0101721. PubMed ID: 34787487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 intra-host evolution during prolonged infection in an immunocompromised patient.
    Quaranta EG; Fusaro A; Giussani E; D'Amico V; Varotto M; Pagliari M; Giordani MT; Zoppelletto M; Merola F; Antico A; Stefanelli P; Terregino C; Monne I
    Int J Infect Dis; 2022 Sep; 122():444-448. PubMed ID: 35724829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2.
    Ruiz-Rodriguez P; Francés-Gómez C; Chiner-Oms Á; López MG; Jiménez-Serrano S; Cancino-Muñoz I; Ruiz-Hueso P; Torres-Puente M; Bracho MA; D'Auria G; Martinez-Priego L; Guerreiro M; Montero-Alonso M; Gómez MD; Piñana JL; ; González-Candelas F; Comas I; Marina A; Geller R; Coscolla M
    mBio; 2021 Dec; 12(6):e0231521. PubMed ID: 34781748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Evolution of SARS-CoV-2 in an Immunocompromised Patient with Non-Hodgkin Lymphoma.
    Borges V; Isidro J; Cunha M; Cochicho D; Martins L; Banha L; Figueiredo M; Rebelo L; Trindade MC; Duarte S; Vieira L; Alves MJ; Costa I; Guiomar R; Santos M; Cortê-Real R; Dias A; Póvoas D; Cabo J; Figueiredo C; Manata MJ; Maltez F; Gomes da Silva M; Gomes JP
    mSphere; 2021 Aug; 6(4):e0024421. PubMed ID: 34319130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing an Amplification Refractory Mutation System-Quantitative Reverse Transcription-PCR Assay for Rapid and Sensitive Screening of SARS-CoV-2 Variants of Concern.
    Xiong D; Zhang X; Shi M; Wang N; He P; Dong Z; Zhong J; Luo J; Wang Y; Yu J; Wei H
    Microbiol Spectr; 2022 Feb; 10(1):e0143821. PubMed ID: 34985323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of two SARS-CoV-2 variants with spike protein mutations to neutralising antibodies.
    Müller K; Girl P; Giebl A; Gruetzner S; Antwerpen M; Khatamzas E; Wölfel R; von Buttlar H
    Virus Genes; 2021 Dec; 57(6):502-509. PubMed ID: 34608598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants.
    Yi C; Sun X; Lin Y; Gu C; Ding L; Lu X; Yang Z; Zhang Y; Ma L; Gu W; Qu A; Zhou X; Li X; Xu J; Ling Z; Xie Y; Lu H; Sun B
    Genome Med; 2021 Oct; 13(1):164. PubMed ID: 34649620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The origins of new SARS-COV-2 variants in immunocompromised individuals.
    Riddell AC; Cutino-Moguel T
    Curr Opin HIV AIDS; 2023 May; 18(3):148-156. PubMed ID: 36977190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Bifluorescent-Based Assay for the Identification of Neutralizing Antibodies against SARS-CoV-2 Variants of Concern
    Chiem K; Morales Vasquez D; Silvas JA; Park JG; Piepenbrink MS; Sourimant J; Lin MJ; Greninger AL; Plemper RK; Torrelles JB; Walter MR; de la Torre JC; Kobie JK; Ye C; Martinez-Sobrido L
    J Virol; 2021 Oct; 95(22):e0112621. PubMed ID: 34495697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases.
    Nayak B; Lal G; Kumar S; Das CJ; Saraya A; Shalimar
    Front Cell Infect Microbiol; 2021; 11():753249. PubMed ID: 34760721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.